Status:
NOT_YET_RECRUITING
Effects of a Multicomponent Protocol With Emphasis on Muscle Power Training on Bradykinesia in Individuals With Parkinson's Disease
Lead Sponsor:
Federal University of Health Science of Porto Alegre
Collaborating Sponsors:
Federal University of Rio Grande do Sul
Conditions:
Parkinson Disease (PD)
Eligibility:
All Genders
50-85 years
Phase:
NA
Brief Summary
Parkinson's disease (PD) is a chronic progressive neurological disorder that involves both motor and non-motor symptoms, culminating in functional decline and disability. One of the main symptoms of P...
Eligibility Criteria
Inclusion
- To be included in the research, individuals must:
- be Diagnosed with Parkinson's disease and classified as 1 to 3 on the Hoehn and Yahr Scale;
- Present rigid akinetic PD;
- Be Aged between 50 and 85 years;
- Achieve a minimum score of 21 points on the Montreal Cognitive Assessment (MoCa);
- Sign the Informed Consent Form (ICF)
Exclusion
- Individuals will be excluded from this study if they present:
- Previous associated neurological diseases;
- Vestibular system disorders;
- Change in the pattern of levodopa use during the study;
- Severe heart disease;
- Uncontrolled arterial hypertension;
- Previous spinal surgeries;
- Tumors or infection of the spinal column;
- Inflammatory diseases of the spinal column;
Key Trial Info
Start Date :
November 1 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
February 1 2026
Estimated Enrollment :
22 Patients enrolled
Trial Details
Trial ID
NCT07172698
Start Date
November 1 2025
End Date
February 1 2026
Last Update
September 15 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Federal University of Health Sciences of Porto Alegre
Porto Alegre, Rio Grande do Sul, Brazil